Dual X-ray Absorptiometry

PROCEDURE18 trials

Sponsors

University of Medicine and Dentistry of New Jersey, SWOG Cancer Research Network, ETOP IBCSG Partners Foundation, M.D. Anderson Cancer Center, Ohio State University Comprehensive Cancer Center

Conditions

Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage 1 Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Blood Pressure Monitoring, AmbulatoryBreast CancerCastration-Resistant Prostate CarcinomaCastration-Sensitive Prostate AdenocarcinomaChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Phase 1

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

RecruitingNCT04851119

Children's Oncology GroupColorectal Carcinoma, Endometrial Carcinoma, Melanoma +19

Start: 2021-11-08End: 2028-06-30Target: 147Updated: 2026-02-24

Phase 2

Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study

RecruitingNCT06039371

University of WashingtonCastration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8

Start: 2024-05-21End: 2027-12-31Target: 69Updated: 2026-01-14

Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer

Not yet recruitingNCT06129851

University of Kansas Medical CenterStage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8

Start: 2023-11-20End: 2026-10-23Target: 90Updated: 2023-11-13

Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial

Not yet recruitingNCT07466498

University of WashingtonCastration-Sensitive Prostate Adenocarcinoma, Metastatic Castration-Sensitive Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8

Start: 2026-08-01End: 2029-06-01Target: 60Updated: 2026-03-12

Phase 3

Vitamin D for Prostate Endocrine Therapy

RecruitingNCT05838716

University of RochesterStage III Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8, Stage I Prostate Cancer AJCC v8 +1

Start: 2023-12-14End: 2029-04-29Target: 240Updated: 2026-01-15

Testing Low Dose Tamoxifen for Invasive Breast Cancer, the (LoTam) Trial

SuspendedNCT06671912

Alliance for Clinical Trials in OncologyAnatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage 1 Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8 +2

Start: 2025-02-19End: 2031-11-30Target: 1156Updated: 2026-03-04

Unknown Phase

Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer

CompletedNCT00176579

University of Medicine and Dentistry of New JerseyOsteoporosis, Prostate Cancer

Start: 2003-06-30End: 2008-07-31Updated: 2011-08-12

S0307A, Long-Term Bone Quality in Women With Breast Cancer Enrolled on Clinical Trial SWOG-S0307

WithdrawnNCT00873808

SWOG Cancer Research NetworkBreast Cancer

Start: 2008-10-31End: 2010-02-28Updated: 2013-04-10

Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02

CompletedNCT00963417

ETOP IBCSG Partners FoundationBreast Cancer, Osteoporosis

Start: 2009-08-03End: 2024-10-23Updated: 2025-07-14

Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer

CompletedNCT02592356

M.D. Anderson Cancer CenterDifferentiated Thyroid Gland Carcinoma, Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma +1

Start: 2015-11-16End: 2024-03-01Updated: 2024-03-05

Quality of Life and Supportive Care Preferences Following Radiation Therapy in Prostate Cancer Survivors

CompletedNCT02704377

Ohio State University Comprehensive Cancer CenterProstate Carcinoma

Start: 2016-05-08End: 2023-04-06Updated: 2023-09-15

Role of Comorbidities in Chronic Heart Failure Study

CompletedNCT02922478

Medical University of GrazBlood Pressure Monitoring, Ambulatory, Comorbidity, Heart Failure +3

Start: 2016-09-30End: 2018-12-20Updated: 2019-06-24

Assessment of Vertebral Fracture Risk for First Time Liver Transplant Candidates

CompletedNCT03811873

Mayo ClinicMetabolic Bone Disease, Secondary Osteoporosis, Transplant-Related Disorder

Start: 2019-02-18End: 2022-08-30Updated: 2023-05-06

Effects of Alternative Healthy Eating Index-Based Diet on Inflammatory Markers and Breast Density in Healthy Participants

CompletedNCT04062955

Fred Hutchinson Cancer CenterHealthy Subject

Start: 2019-10-28End: 2020-11-19Updated: 2021-01-22

Bone Loss in Melanoma Survivors Receiving Immunotherapy

TerminatedNCT04516122

M.D. Anderson Cancer CenterClinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Pathologic Stage IIIA Cutaneous Melanoma AJCC v8 +5

Start: 2021-05-10End: 2025-06-18Updated: 2025-08-17

The Effects of Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients

RecruitingNCT05876923

Mayo ClinicChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Indolent Non-hodgkin Lymphoma

Start: 2023-06-12End: 2028-04-30Target: 70Updated: 2025-11-07

Low-Intensity Mechanical Stimulation for Hematologic Malignancy Patients

RecruitingNCT05893940

Roswell Park Cancer InstituteHematopoietic and Lymphoid System Neoplasm

Start: 2023-08-14End: 2026-09-01Target: 75Updated: 2025-12-03

Exercise Training for the Improvement of Immune Activity and Treatment Outcomes During Immunotherapy for Non-small Cell Lung Cancer, BOOST Trial

RecruitingNCT06983899

Fred Hutchinson Cancer CenterLung Non-Small Cell Carcinoma

Start: 2026-01-28End: 2028-05-31Target: 100Updated: 2026-02-06

Related Papers

A phase 1/2 study of the TBL1 inhibitor, tegavivint (BC2059), in patients (pts) with advanced hepatocellular carcinoma (aHCC) with β-catenin activating mutations.

Journal of Clinical Oncology2024-06-015 citations